Cargando…
Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection
Tuberculosis relapse following drug treatment of active disease is an important global public health problem due to the poorer clinical outcomes and increased risk of drug resistance development. Concurrent infection with HIV, including in those receiving anti-retroviral therapy (ART), is an importa...
Autores principales: | Huante, Matthew B., Saito, Tais B., Nusbaum, Rebecca J., Naqvi, Kubra F., Chauhan, Sadhana, Hunter, Robert L., Actor, Jeffrey K., Rudra, Jai S., Endsley, Mark A., Lisinicchia, Joshua G., Gelman, Benjamin B., Endsley, Janice J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176873/ https://www.ncbi.nlm.nih.gov/pubmed/32373548 http://dx.doi.org/10.3389/fcimb.2020.00150 |
Ejemplares similares
-
Helper T cell bias following tuberculosis chemotherapy identifies opportunities for therapeutic vaccination to prevent relapse
por: Martinez-Martinez, Yazmin B., et al.
Publicado: (2023) -
Myeloid C-Type Lectin Receptors in Tuberculosis and HIV Immunity: Insights Into Co-infection?
por: Naqvi, Kubra F., et al.
Publicado: (2020) -
Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse
por: Endsley, Janice J., et al.
Publicado: (2021) -
Self-adjuvanting nanovaccines boost lung-resident CD4(+) T cell immune responses in BCG-primed mice
por: Files, Megan A., et al.
Publicado: (2022) -
Pulmonary Tuberculosis in Humanized Mice Infected with HIV-1
por: Nusbaum, Rebecca J., et al.
Publicado: (2016)